DSPE-PEG (2000) -Mannose
DSPE-PEG (2000) -Mannose can be used to construct liposome vaccines to improve the anti-tumor effect of vaccines[1].
Product Specifications
CAS Number
1829524-73-3
UNSPSC
12352200
Target
Biochemical Assay Reagents
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
90.0
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CCCCCCCCCCCCCCCCCC(O[C@@H](COP(OCCNC(OCCOCCNC(NC1=CC=C(O[C@@H]2[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)C=C1)=S)=O)(O)=O)COC(CCCCCCCCCCCCCCCCC)=O)=O.[n]
Molecular Weight
2000 (Average)
References & Citations
[1]Zhao Y, et al. Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice. Int J Nanomedicine. 2020 Dec 1;15:9571-9586.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Biochemical Assay Reagents
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
124831-HRP 100 µL
CEBPG (CCAAT/Enhancer-binding Protein gamma, C/EBP gamma) (HRP)
Sign In for Pricing
View Details 
36898116 3x 1.0 µg
Pla2g12a sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details